Form 4: Denali Therapeutics Officer Sells Shares to Cover Tax Obligations

Alexander O. Schuth, COFO and Secretary of Denali Therapeutics Inc., sold 2,272 shares of common stock on August 13, 2024, to satisfy tax obligations related to vested restricted stock units.

Summary

• On August 13, 2024, Alexander O. Schuth, the COFO and Secretary of Denali Therapeutics Inc., sold 2,272 shares of the company's common stock.
• The sale was executed at a price of $22.89 per share.
• This transaction was to cover tax obligations related to the settlement of previously vested restricted stock units.
• Following the transaction, Schuth directly owns 186,419 shares, which includes 123,810 RSUs and 1,350 shares acquired under the ESPP Purchase on May 31, 2024.
• Additionally, Schuth indirectly owns 523,749 shares through The Schuth Family Trust U/A DTD 06/05/2017, where he serves as trustee.

Sentiment

Score: 5

Explanation: This is a neutral event. An executive selling shares to cover tax obligations is a common occurrence and doesn't necessarily reflect a positive or negative outlook on the company.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. This sale appears to be a standard transaction to cover tax obligations and doesn't necessarily indicate a change in the executive's long-term outlook for the company.

Stakeholder Impact

• The sale of shares by an insider could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect on shareholders, employees, customers, suppliers, or creditors.

Key Dates